Navigation Links
Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers
Date:7/28/2014

c AB). Volumetric breast density was measured for each participant using VolparaDensity. Study participants also donated blood for genotyping and filled out a detailed questionnaire.

Results demonstrated that in a high-throughput setting VolparaDensity performs well and in accordance with the behavior of established density measures. Volumetric density was positively associated with nulliparity (never having given birth), age at first birth, hormone use, benign breast disease and family history of breast cancer, and negatively with age and postmenopausal status. Importantly, the method showed good agreement by side and by view and distributions of volume density were similar across the different mammography systems. Based on the results, researchers concluded that automated measurement of volumetric mammographic density using VolparaDensity is a promising tool for widespread breast cancer risk assessment.

"One of the limitations of current screening strategies," according to Volpara Solutions Chief Scientist and CEO, Dr. Ralph Highnam, "is that they are based solely on age, ignoring the fact that a woman's lifetime risk is determined by other common risk factors. After age, mammographic density is the strongest breast cancer risk factor. As a result of the Karolinska's study, VolparaDensity's volumetric assessment of mammographic density is continuing to display its promise as a highly effective tool for optimizing screening programs where resources and extra imaging modalities can be targeted to those with the highest density.

"The KARMA study is one of the best organized and most exciting studies that we are participating in globally. This validation of VolparaDensity for consistency is a great starting point for a whole range of projects we aim to complete with KARMA as we pursue our joint aim of reducing the mortality and incidence of breast cancer," said Dr. Highnam.

Cleared by the FDA, HealthCa
'/>"/>

SOURCE Volpara Solutions
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dr. Michael Gabriel of GPM Pediatrics, a Noted Staten Island Pediatrics Clinic, Comments on Study, Which Names Grief as a Cause of Obesity in Children
2. Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP
3. Celsion Announces Positive Interim Data Update from its Phase 2 DIGNITY Study in Breast Cancer
4. Medication Non-Adherence Issue Highlighted in Annals of Internal Medicine Study Could Be Eliminated by a New Direct-to-Consumer Delivery Channel Ensuring Consistent Medication Appearance
5. EasyOne Pro from ndd Medical Technologies Chosen Again as the Exclusive PFT Testing Technology in Phase 2 of COPDGene Study
6. New Study: H.R. 4577 to Cost $21 Billion over 10 Years
7. Glide Pharma Completes Successful Proof-of-Concept Study with Novel Solid Dose Formulation of Octreotide
8. Isis Pharmaceuticals Initiates Phase 2 Study of ISIS-APO(a) Rx in Patients with High Lp(a)
9. Decline in Prescription Drug Misuse More than Twice as High in States with Broad Drug Abuse Prevention Programs, New Quest Diagnostics Health Trends Study Finds
10. Seres Health Completes Enrollment in a Clinical Study for SER-109 in Recurrent Clostridium difficile Infection and Announces Positive Preliminary Data
11. Avanir Pharmaceuticals Announces Presentation of Positive Early Results from PRISM II Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... NEW YORK , Sept. 16, 2014  Relmada ... therapies for the treatment of chronic pain, announced today ... Sloan Kettering Cancer Center (MSKCC) in a series of ... ER, a new tamper-resistant, extended release form of levorphanol. ... investigator for these studies. Dr. Pasternak ...
(Date:9/15/2014)... NEW YORK , Sept. 16, 2014 ... Neuropathy Foundation (HNF) announced today an agreement to collaborate ... disease and support the development of a stronger CMT ... provide financial support to several HNF,s initiatives including: ... section in the HNF website featuring  HNF newsletters, materials ...
(Date:9/15/2014)... , Sept. 15, 2014 /PRNewswire/ -  Pivotal Therapeutics ... specialty pharmaceutical company with a focus on Omega-3 ... today that the Board of Directors approved the ... an advisor at the close of business on Friday, ... of 1,000,000 common shares of the Company were ...
Breaking Medicine Technology:Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 2Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 3Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 2Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 3Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 4Pivotal Therapeutics Grants Incentive Stock Options 2
... Publicis Groupe announced today that ... Healthcare Communications Group (PHCG), powerfully redefining Publicis Groupe,s ... healthcare sector. PHCG is the world,s ... Digitas Health and Razorfish Health -- Publicis Groupe,s ...
... 27, 2011 Halozyme Therapeutics, Inc. (NASDAQ: ... targeting the extracellular matrix for the diabetes, ... results from a study in patients with type 1 ... Phase 1b study was conducted as a randomized, double-blind, ...
Cached Medicine Technology:Publicis Healthcare Communications Group Redefines Publicis Groupe's Healthcare Client Offering by Joining Forces with Digitas Health and Razorfish Health 2Publicis Healthcare Communications Group Redefines Publicis Groupe's Healthcare Client Offering by Joining Forces with Digitas Health and Razorfish Health 3Publicis Healthcare Communications Group Redefines Publicis Groupe's Healthcare Client Offering by Joining Forces with Digitas Health and Razorfish Health 4Publicis Healthcare Communications Group Redefines Publicis Groupe's Healthcare Client Offering by Joining Forces with Digitas Health and Razorfish Health 5Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial 2Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial 3Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial 4
(Date:9/16/2014)... 16, 2014 Non-small cell lung cancer (NSCLC) survivors ... at the time of diagnosis have a lower ... compared to those who are current smokers, suggesting ... higher risk of SPLC, according to research presented ... (ASTRO,s) 56th Annual Meeting. , The analysis studied ...
(Date:9/16/2014)... 16, 2014 An experimental positron emission ... disease while a person is still alive, according to ... Medicine at Mount Sinai, and at Molecular Neuroimaging (MNI) ... the journal Translational Psychiatry. , Specifically, the study results ... which is designed to latch onto a protein called ...
(Date:9/16/2014)... VA (PRWEB) September 16, 2014 Gary ... Republic of China, has selected Worldwide Speakers Group for ... former U.S. Secretary of Commerce and Governor of Washington, ... foremost authorities on U.S.-China relations, global expansion, and business ... on global competitiveness and how to grow an organization’s ...
(Date:9/16/2014)... September 16, 2014 The Muscular ... of flu vaccines for individuals affected by muscle ... and other neuromuscular diseases. , MDA offers this ... muscle disease who, because of compromised respiratory function ... the lungs — are at increased risk of ...
(Date:9/16/2014)... Insuranceservicecompany.com has released a new blog post explaining ... , Whole life insurance can provide financial security for ... an investment tool. Clients can save money for retirement using ... A whole life insurance plan features a savings account which ... this policy to be profitable, clients should purchase it as ...
Breaking Medicine News(10 mins):Health News:NSCLC patients who never smoked or who quit smoking have lower risk of developing secondary cancers 2Health News:NSCLC patients who never smoked or who quit smoking have lower risk of developing secondary cancers 3Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 2Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 3Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 4Health News:Gary Locke, Former Ambassador to China, Selects Worldwide Speakers Group for Exclusive Lecture Representation 2Health News:MDA Offers Flu Shots to Those Affected by Muscle Disease 2Health News:Whole Life Insurance Can Be A Good Investment Tool for Retirement! 2
... The Midwest Center for Stress and Anxiety announced ... the premier online destination for news, information and solutions ... new site features an enhanced user interface with access ... most pressing and relevant stress-related issues, and the newest ...
... Arizona Technology Enterprises (AzTE), the technology venturing arm ... technology forum for investors on Feb. 12 and 13, ... in Scottsdale, AzTE collaborated with its tech transfer partner, ... The forum was sponsored and supported by Silicon ...
... FRANCISCO, Feb. 18 DIAKADI Body, Personal ... its outdoor boot camps, the hottest and most economical workout ... a.m., individuals of all fitness levels will gather in Mission ... Stairs) to take their workout to the next level. ...
... Verathon(R) is pleased to announce,the GlideScope(R) Ranger Video ... States Army.(1) This certificate allows the,device to be ... of the most,demanding military settings. , ... The U.S. Army Airworthiness ...
... Achieves 20% Sales Growth over Q3 FY 08 and Record Quarterly ... ) today announced results for the quarter ended January 23, 2009. ... of fiscal 2009 compared to the third quarter of fiscal 2008 ... Net sales of $35.3 million, a 20% increase ...
... proves faster, more accurate in early tests , , WEDNESDAY, ... make prescribing the widely used anticoagulant warfarin safer by ... , The U.S. Food and Drug Administration estimates that ... blood clots that can cause strokes. Reasons range from ...
Cached Medicine News:Health News:The Midwest Center for Stress and Anxiety Re-launches Website for Stress, Anxiety, and Depression 2Health News:Arizona Technology Enterprises (AzTE) Hosts the ASU Tech Forum for the Investment Community 2Health News:Arizona Technology Enterprises (AzTE) Hosts the ASU Tech Forum for the Investment Community 3Health News:Arizona Technology Enterprises (AzTE) Hosts the ASU Tech Forum for the Investment Community 4Health News:Back by Popular Demand! DIAKADI Body Announces Its Spring Edition of Outdoor Boot Camps 2Health News:Back by Popular Demand! DIAKADI Body Announces Its Spring Edition of Outdoor Boot Camps 3Health News:GlideScope(R) Ranger Video Laryngoscope by Verathon(R) Awarded Airworthiness Certification by U.S. Army 2Health News:GlideScope(R) Ranger Video Laryngoscope by Verathon(R) Awarded Airworthiness Certification by U.S. Army 3Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 2Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 3Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 4Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 5Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 6Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 7Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 8Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 9Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 10Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 11Health News:Genetics May Help Fine-Tune Warfarin Dosage 2Health News:Genetics May Help Fine-Tune Warfarin Dosage 3Health News:Genetics May Help Fine-Tune Warfarin Dosage 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: